These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 10564835

  • 21. Alpha-Asarone incorporated in mixed micelles suitable for intravenous administration: formulation, in-vivo distribution and anaphylaxis study.
    Ren C, Gong T, Sun X, Zhang Z, Zhang Y.
    Pharmazie; 2011 Nov; 66(11):875-80. PubMed ID: 22204134
    [Abstract] [Full Text] [Related]

  • 22. Effect of Wuzhi tablet (Schisandra sphenanthera extract) on the pharmacokinetics of cyclosporin A in rats.
    Xue XP, Qin XL, Xu C, Zhong GP, Wang Y, Huang M, Bi HC.
    Phytother Res; 2013 Aug; 27(8):1255-9. PubMed ID: 22996305
    [Abstract] [Full Text] [Related]

  • 23. Cyclosporin A in fat emulsion carriers: experimental studies on pharmacokinetics and tissue distribution.
    Tibell A, Lindholm A, Säwe J, Chen G, Norrlind B.
    Pharmacol Toxicol; 1995 Feb; 76(2):115-21. PubMed ID: 7746794
    [Abstract] [Full Text] [Related]

  • 24. Relative tissue distributions of cyclosporine and sirolimus after concomitant peroral administration to the rat: evidence for pharmacokinetic interactions.
    Napoli KL, Wang ME, Stepkowski SM, Kahan BD.
    Ther Drug Monit; 1998 Apr; 20(2):123-33. PubMed ID: 9558125
    [Abstract] [Full Text] [Related]

  • 25. Pharmacokinetic and pharmacodynamic evaluation of cyclosporin A O/W-emulsion in rats.
    Kim SJ, Choi HK, Lee YB.
    Int J Pharm; 2002 Dec 05; 249(1-2):149-56. PubMed ID: 12433443
    [Abstract] [Full Text] [Related]

  • 26. Ethyl docosahexaenoate decreased Neoral absorption due to particle size enlargement.
    Hirunpanich V, Sugiyama E, Sato H.
    Int J Pharm; 2008 Sep 01; 361(1-2):251-2. PubMed ID: 18577438
    [Abstract] [Full Text] [Related]

  • 27. Comparative effects of PEG-containing liposomal formulations on in vivo pharmacokinetics of streptokinase.
    Jin SE, Kim IS, Kim CK.
    Arch Pharm Res; 2015 Oct 01; 38(10):1822-9. PubMed ID: 25851624
    [Abstract] [Full Text] [Related]

  • 28. Self-micellizing solid dispersion of cyclosporine A with improved dissolution and oral bioavailability.
    Onoue S, Suzuki H, Kojo Y, Matsunaga S, Sato H, Mizumoto T, Yuminoki K, Hashimoto N, Yamada S.
    Eur J Pharm Sci; 2014 Oct 01; 62():16-22. PubMed ID: 24836392
    [Abstract] [Full Text] [Related]

  • 29. Promotion of the selective lymphatic delivery of cyclosporin A by lipid-surfactant mixed micelles.
    Takada K, Shibata N, Yoshimura H, Masuda Y, Yoshikawa H, Muranishi S, Oka T.
    J Pharmacobiodyn; 1985 Apr 01; 8(4):320-3. PubMed ID: 4032221
    [Abstract] [Full Text] [Related]

  • 30. Liposomal formulations of Cyclosporin A: a biophysical approach to pharmacokinetics and pharmacodynamics.
    Fahr A, Seelig J.
    Crit Rev Ther Drug Carrier Syst; 2001 Apr 01; 18(2):141-72. PubMed ID: 11325030
    [Abstract] [Full Text] [Related]

  • 31. Comparative Biodistribution and Pharmacokinetic Analysis of Cyclosporine-A in the Brain upon Intranasal or Intravenous Administration in an Oil-in-Water Nanoemulsion Formulation.
    Yadav S, Gattacceca F, Panicucci R, Amiji MM.
    Mol Pharm; 2015 May 04; 12(5):1523-33. PubMed ID: 25785492
    [Abstract] [Full Text] [Related]

  • 32. Lung deposition of a liposomal cyclosporine A inhalation solution in patients after lung transplantation.
    Behr J, Zimmermann G, Baumgartner R, Leuchte H, Neurohr C, Brand P, Herpich C, Sommerer K, Seitz J, Menges G, Tillmanns S, Keller M, Munich Lung Transplant Group.
    J Aerosol Med Pulm Drug Deliv; 2009 Jun 04; 22(2):121-30. PubMed ID: 19422312
    [Abstract] [Full Text] [Related]

  • 33. In vitro and in vivo characterization on amorphous solid dispersion of cyclosporine A for inhalation therapy.
    Onoue S, Sato H, Kawabata Y, Mizumoto T, Hashimoto N, Yamada S.
    J Control Release; 2009 Aug 19; 138(1):16-23. PubMed ID: 19376169
    [Abstract] [Full Text] [Related]

  • 34. A prospective cross-over study comparing the pharmacokinetics of cyclosporine A and its metabolites after oral versus short-time intravenous cyclosporine A administration in pre-heart transplant patients.
    Lehle K, Kirchner GI, Rupprecht L, Gruber M, Birnbaum DE, Schmid FX, Preuner JG.
    Transplant Proc; 2007 Dec 19; 39(10):3323-8. PubMed ID: 18089380
    [Abstract] [Full Text] [Related]

  • 35. Pharmacokinetics and biodistribution of polymeric micelles of paclitaxel with Pluronic P123.
    Han LM, Guo J, Zhang LJ, Wang QS, Fang XL.
    Acta Pharmacol Sin; 2006 Jun 19; 27(6):747-53. PubMed ID: 16723095
    [Abstract] [Full Text] [Related]

  • 36. Reversal of multidrug resistance to epirubicin by cyclosporin A in liposomes or intralipid.
    Lo YL, Liu FI, Yang JM, Cherng JY.
    Anticancer Res; 2001 Jun 19; 21(1A):445-50. PubMed ID: 11299776
    [Abstract] [Full Text] [Related]

  • 37. Cyclosporine and sirolimus pharmacokinetics and drug-to-drug interactions in kidney transplant recipients.
    Felipe CR, Park SI, Pinheiro-Machado PG, Garcia R, Casarini DE, Moreira S, Tedesco-Silva H, Medina-Pestana JO.
    Fundam Clin Pharmacol; 2009 Oct 19; 23(5):625-31. PubMed ID: 19656203
    [Abstract] [Full Text] [Related]

  • 38. Distribution of cyclosporin in organ transplant recipients.
    Akhlaghi F, Trull AK.
    Clin Pharmacokinet; 2002 Oct 19; 41(9):615-37. PubMed ID: 12126456
    [Abstract] [Full Text] [Related]

  • 39. Development of a polymeric micellar formulation for valspodar and assessment of its pharmacokinetics in rat.
    Binkhathlan Z, Hamdy DA, Brocks DR, Lavasanifar A.
    Eur J Pharm Biopharm; 2010 Jun 19; 75(2):90-5. PubMed ID: 20332028
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.